Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Losartan Market Expected to Grow Between 2025 And 2029?
The market size for losartan has been on a continuous growth trajectory in the past few years. The forecast suggests an increase from $1.44 billion in 2024 to $1.49 billion in 2025, with a compound annual growth rate (CAGR) of 3.6%. The market’s historical expansion owes much to factors such as the ageing population, heightened healthcare spending, a surge in cases of diabetic nephropathy, increased public knowledge around managing blood pressure, and the widespread use of generic ARBs.
In the coming years, steady growth is anticipated for the losartan market, with an expected rise to $1.76 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 4.2%. Factors contributing to this projected growth during the forecast period include an increased demand for affordable antihypertensive medication, a heightened emphasis on preventive healthcare, a growing incidence of lifestyle-related diseases, the expansion of healthcare availability in burgeoning markets, and the ongoing introduction of generic formulas. Forecasts for this period also predict novel advancements in drug delivery systems, the creation of fixed-dose combination treatments, innovation in drug formulation technologies, enhanced manufacturing processes, and the emergence of personalized medicine strategies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Losartan Market?
The escalating occurrence of hypertension is anticipated to drive the expansion of the losartan market in the future. Hypertension, an ongoing high blood pressure condition, increases the risk of heart disease, stroke, and other serious health issues. A rise in hypertension cases is associated with high-salt diets and processed food intake, resulting in fluid build-up and added strain on the heart. Losartan aids in hypertension management by obstructing angiotensin II, a hormone that constricts blood vessels, hence facilitating their relaxation and dilation. This reduces blood pressure and lightens the burden on the heart. For example, the American Heart Association, a nonprofit organization based in the US, reported in January 2024 that there were 131,454 deaths predominantly attributed to high blood pressure in 2022, a surge from 124,508 deaths in 2021. Consequently, the escalating occurrence of hypertension is fueling the expansion of the losartan market.
Which Primary Segments of the Losartan Market Are Driving Growth and Industry Transformations?
The losartanmarket covered in this report is segmented –
1) By Dosage: Tablet; Powder; Suspension
2) By Source: Contract Manufacturing Organizations; In-House
3) By Distribution Channel: Online; Offline
4) By Application: Hypertension; Stroke; Diabetic Nephropathy; Other Applications
5) By End-User: Adult; Pediatric
Subsegments:
1) By Tablet: 25 Milligrams (mg); 50 Milligrams (mg); 100 Milligrams (mg)
2) By Powder: 25 Milligrams (mg); 50 Milligrams (mg); 100 Milligrams (mg)
3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL); 10 Milligrams (mg) Per 5 Milliliters (mL); 25 Milligrams (mg) Per 5 Milliliters (mL)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24284&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Losartan Market?# Market?
North America was the largest region in the losartan market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Losartan Market?
Leading enterprises in the losartan market are concentrating on product innovation and gaining necessary approvals, such as those needed for losartan potassium oral suspension. This is aimed at increasing patient adherence and widening the scope of therapeutic uses. Losartan potassium oral suspension is a liquid medication designed for individuals who have difficulty ingesting tablets. An example of this emerged in March 2025, when US-based biopharmaceutical firm Scienture Holdings Inc. was granted FDA approval for Arbli. This ready-to-use liquid formulation is meant for managing hypertension, reducing the risk of stroke in hypertensive patients showing signs of left ventricular hypertrophy, and treating diabetic nephropathy in patients with type 2 diabetes. It ensures accurate dosage without the need for compounding and comes in a 165 mL peppermint-flavored suspension (10 mg/mL) that retains its potency for 18 months under room temperature conditions.
View the full report here:
https://www.thebusinessresearchcompany.com/report/losartan-global-market-report
What Parameters Are Used to Define the Losartan Market?
Losartan is an angiotensin II receptor blocker (ARB) commonly used to treat high blood pressure and reduce the risk of stroke in patients with hypertension. It works by relaxing blood vessels, making it easier for the heart to pump blood. Losartan lowers blood pressure, improves heart function, and protects kidney health, especially in patients with diabetes.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24284
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model